The steep rise in the Automated Compounding Device (Oncology) Market can be ascribed to the emergent need to reduce medicinal errors and a growing preference of cancer patients for personalized ...

ENGLEWOOD, Colo., Nov. 2, 2011 /PRNewswire/ -- Baxa Corporation, a leading provider of medical devices and systems that automate pharmacy operations, has released a software upgrade for its ExactaMix® ...

Ottawa, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The global automated pharmacy compounding systems market size is calculated at USD 3.12 billion in 2026 and is expected to reach around USD 5.27 billion by ...

PORTLAND, Ore., Nov. 19, 2025 /PRNewswire/ -- Compounding chemotherapy refers to the process of preparing personalized chemotherapy treatments by combining or altering the components of pharmaceutical ...

ENGLEWOOD, Colo., April 7 /PRNewswire/ -- Baxa Corporation, a leading provider of medical devices and systems that automate pharmacy operations and increase patient safety, today announced the release ...

As technology has progressed, automation has been successfully introduced into several areas of healthcare practice, such as surgery and data processing, providing a range of benefits from greater ...

Dublin, Aug. 25, 2020 (GLOBE NEWSWIRE) -- The "Asia Pacific Automated Compounding Systems Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product Type; End User, and Country" report ...

Hospital pharmacies worldwide use ExactaMix 2400 (EM2400) and ExactaMix 1200 (EM1200) to compound large- and small-volume parenteral doses. Baxa Corporation leads the ACD category with 65% of the ...

Key developments in this market include advancements in compounding technologies, such as automated compounding devices and robotic assistance, enhancing accuracy and safety in drug preparation.